SEC Form 4 · accession 0001127602-16-059402
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gloria M McCarthy
Officer — EVP & Chief Administrative Off
Period of report
Aug 1, 2016
Accepted (ET)
Aug 3, 2016 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 1, 2016 | M | 4,186 | $89.44 | A | 49,426 | D | |
| Common StockF2 | Aug 1, 2016 | S | 3,600 | $130.25 | D | 45,826 | D | |
| Common StockF3 | Aug 1, 2016 | S | 586 | $131.28 | D | 45,240 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $89.44 | Aug 1, 2016 | M | 4,186 | D | — | Mar 3, 2021 | Common Stock | 4,186 | 14,871 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2016.
- F2This transaction was executed in multiple trades at prices ranging from $130.00 to $130.74. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $131.10 to $131.52. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4The option, representing a right to purchase a total of 25,671 shares, became exercisable in three semi-annual installments of 4,278 shares each and three semi-annual installments of 4,279 shares each beginning on September 3, 2014, which was the six-month anniversary of the date on which the option was granted.